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Laparoscopy and Robotic Surgery
Nonmodifiable Factors and Complications Contribute
to Length of Stay in Robot-Assisted Partial Nephrectomy
Jeffrey A. Larson, MD,1 Jihad H. Kaouk, MD,2 Michael D. Stifelman, MD,3 Craig G. Rogers, MD,4
Mohamad E. Allaf, MD,5 Aaron Potretzke, MD,1 Susan Marshall, MD,3 Homayoun Zargar, MD,2
Mark W. Ball, MD,5 and Sam B. Bhayani, MD1
Abstract
Introduction/Objective: Robotic-assisted partial nephrectomy (RPN) offers a mean length of stay (LOS) of 2 to
3 days. The purpose of this study is to determine the impact of modifiable and nonmodifiable risk factors on
hospital LOS after RPN.
Patients and Methods: We retrospectively reviewed our prospectively maintained database to identify all
patients undergoing RPN for localized tumors at five US centers from 2007 to 2013. Patient and tumor
characteristics were compared among hospital LOS groups. Associated factors were modeled using univariate
and multivariate cumulative logistic regression to determine factors predictive of hospital LOS.
Results: One thousand five hundred thirty-two patients were grouped into LOS 1 to 3 days (1298, 84.1%),
LOS= 4 days (133, 8.6%), and LOS > 4 days (110, 7.2%). Patient demographics were similar between groups.
Patients in the LOS= 4 and LOS > 4 day groups were more likely to have a higher Charlson comorbidity index
score (mean 2.2, 3.1 and 3.8; p< 0.001), higher nephrometry score (mean 7.1, 7.6, 7.8; p= 0.0002), and larger
tumors (mean 2.9, 3.6 and 3.5 cm; p< 0.0001) than those in the LOS 1 to 3 day group. Significant differences in
complication rates were observed when comparing LOS 1–3 (116, 8.9%), LOS= 4 (40, 30%), and LOS > 4 (59,
54%). According to the Clavien–Dindo classification of surgical complications, 11 grade 3 and 11 grade 4
complications occurred in patients with an LOS of 4 or more days ( p < 0.0001). Postoperative transfusion, deep
vein thrombosis, pulmonary embolism, atrial fibrillation, dyspnea/atelectasis, ileus, and acute renal failure each
significantly predicted a hospital LOS > 4 days ( p < 0.001).
Conclusion: 15.8% of patients undergoing RPN have an LOS of 4 days or more. Longer LOS was indepen-
dently associated with higher Charlson index, nephrometry score (nonmodifiable factors), and periopera-
tive complications (potentially modifiable). These data may be useful in perioperative counseling and payer
precertification.
Introduction
The incidence of small renal masses has continued torise over the last decade, largely due to the increased
detection by modern abdominal imaging. While many pa-
tients still undergo radical nephrectomy (RN), evidence
supports nephron-sparing surgery, which offers favorable
oncologic outcomes with preservation of renal function as-
sociated with improvement in cardiovascular morbidity and
mortality.1–5 As such, the American Urological Association
guidelines currently recommend partial nephrectomy (PN) as
the standard of care for managing T1a tumors and as an
alternative treatment option for T1b tumors.6 PN can be ac-
complished via a variety of modalities, including the open,
laparoscopic, and robotic approaches.
While the mean hospital length of stay (LOS) for robotic-
assisted partial nephrectomy (RPN) is shorter compared with
open surgery, a subset of patients still requires longer hos-
pitalizations.7,8 With increased scrutiny on healthcare utili-
zation and a pressure to reduce costs, analysis of hospital LOS
is essential for identifying predictors that can be used in
preoperative planning and perioperative quality control and
process improvement.9 This may become more important
with the implementation of the ‘‘two-midnight rule’’ of
Centers for Medicare & Medicaid Services, and the possi-
bility of a specific LOS impacting reimbursement.10 In this
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context, we sought to identify and describe the characteristics
present in patients requiring a longer-than-expected length of
hospital stay after robotic PN.
We have previously reported our multi-institutional com-
plication experience with RPN in 886 patients across five cen-
ters. Expansion of the series enables a more in-depth evaluation
of LOS, specifically assessing factors contributing to an ex-
tended hospital LOS in a large cohort of 1532 patients who
underwent robotic PN in five US centers.
Materials and Methods
With institutional review board approval, we performed a
retrospective review of de-identified, consented, prospec-
tively maintained databases at five US centers, evaluating all
patients who underwent RPN from June 2007 to August 2013.
Preoperative computed tomography or magnetic resonance
imaging demonstrated contrast-enhancing renal masses in all
patients.
The patients were divided into three groups according to
hospital LOS. The groups were chosen based on expected
admission lengths. Group 1 included all patients discharged
in 1 to 3 days, which is the expected LOS for RPN in pub-
lished series; Group 2 included patients discharged on post-
operative day (POD) 4, reflecting a slightly prolonged LOS;
and Group 3 included all those who had a hospital stay of 5 or
more days, reflecting a significant deviation from the ex-
pected LOS.
The RENAL nephrometry scoring system11 was used to
stratify tumor complexity, and the Clavien system12 was used
to grade complication severity.
All procedures were performed using the da Vinci surgical
System (Intuitive, Sunnyvale, CA) through a transperitoneal
or retroperitoneal approach as previously described.13,14
Briefly, the renal hilum is dissected, allowing individual
clamping of the renal artery and vein with bulldog clamps, or
a selective clamp technique. Intraoperative ultrasonography
aids in identifying the tumor margin for resection. Tumor
excision and sutured renorrhaphy are then performed. Similar
techniques are used among all centers.
Data collection and analysis
Staff physicians and data managers compiled data for spec-
ified patient demographics, tumor characteristics, and peri-
operative outcomes.Complicationswere recordedprospectively
and classified by Clavien grade.
Hemorrhage was defined as bleeding requiring blood
transfusion or therapeutic intervention.
Descriptive statistics were used to summarize patient and
surgical factors. Both cumulative and multivariate logit re-
gression models were used to test the associations of patient-
related and surgical factors to the hospital LOS. SAS 9.3
software was used to perform all statistical analyses with




Table 1 summarizes the clinical and pathologic charac-
teristics, and perioperative outcomes of the 1532 patients who
underwent RPN at five centers. There were 1298 patients
discharged in 1 to 3 days, 133 discharged on day 4, and 110
patients discharged in 5 or more days.
Figure 1 illustrates the LOS categorized by POD. There
were 86 (5.6%) patients discharged on POD 1, 795 (51.6%)
on day 2, 417 (27.1%) on day 3, 133 (8.6%) on day 4, and 110
(7.2%) who stayed for 5 or more days.
Hospital LOS predictors
On univariate analysis, lower mean age was associated
with a shorter LOS (58.8 vs 59.7 vs 63.5 years; p< 0.001).
Higher median Charlson comorbidity index (CCI) was asso-
ciated with a longer LOS (2.2 vs 3.1 vs 3.8, p < 0.0001) as was
a higher median American Society of Anesthesiologists
(ASA) (2.5 vs 2.6 vs 2.8, p< 0.0001). Preoperative estimated
GFR was higher in patients with a low LOS (86.1 vs 81.2 vs
74.4, p < 0.0001). Larger tumors were associated with longer
LOS (2.9 vs 3.6 vs 3.7 cm, p < 0.0001) as were more complex
tumors as measured by R.E.N.A.L. nephrometry score (7.1,
7.6, 7.8, p = 0.0002). Other patient and tumor characteristics,
including gender, race, BMI, previous abdominal surgery,
tumor location, and laterality, were not significantly different
between the groups (all p > 0.05).
Longer warm ischemia time (WIT) (18.7 vs 20.8 vs 23.1
minutes, p< 0.0001), operative time (175 vs 197 vs 200 min-
utes, p< 0.0001), and higher blood loss (164 vs 286 vs 312mL,
p< 0.0001) were associated with longer hospital LOS. With
regard to the type of vascular clamping (zero ischemia, artery
only, and total occlusion), the three groups were similar
( p= 0.411).
After adjustment for age, gender, BMI, CCI, ASA, patho-
logic size, nephrometry score, laterality, clamping technique,
WIT, EBL, complication, and complication Clavien grade,
the variables predictive of longer LOSwere age-adjusted CCI
(odds ratio [OR] 2.23, 95% confidence interval [CI] 1.52–
3.29, p < 0.0001), nephrometry score (OR 1.13, 95%CI 1.01–
1.26, p = 0.041), and postoperative complications (OR 2.27,
95%CI 1.91–2.7, p < 0.0001). Age, gender, BMI, ASA, tumor
size, and WIT were not associated with LOS (Table 2).
Postoperative complications classified by Clavien grade
and organ system are listed in Table 3. A total of 255 post-
operative complications occurred in 215 patients; of these, 83
(32.5%) were classified as Clavien 1, 125 (49%)were Clavien
2, 23 (9%) were Clavien 3a, 10 (3.9%) were Clavien 3b, 13
(5.1%) were Clavien 4a, and 1 (0.4%) was Clavien 4b. There
were no complication-related deaths (Clavien 5). Two pa-
tients required temporary hemodialysis for acute renal failure;
no patient required permanent dialysis. Of the 14 patients with
a Clavien 4 complication, 9 (65%) required a hospitalization
greater than 4 days.
With an overall complication rate of 14%, there was a
significant difference between patients in the hospital for 1 to
3 days (8.9%) compared with those for 4 (30%) and 5 or more
days (54%). Hemorrhagic complications were the most
common, occurring almost thrice more often than cardiac
complications, which were the second most prevalent type of
complication in patients staying > 4 days (Table 4).
Specific complications were analyzed for their individual
effect on a hospital LOS; their incidence in patients requiring
a hospital LOS greater than 4 days is listed in Table 5. There
was a significant correlation between LOS > 4 days and both
perioperative bleeding requiring transfusion ( p £ 0.001) and
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identified postoperative hematoma requiring transfusion
( p £ 0.001). The occurrence of a deep vein thrombosis (DVT)
was significantly correlated with LOS, as was the diagnosis
of pulmonary embolism ( p £ 0.001). We found that atrial
fibrillation was the most significant cardiac complication
contributing to LOS ( p £ 0.001). For nonembolism pulmo-
nary complication, dyspnea and atelectasis requiring oxygen
therapy were significant ( p £ 0.001). The occurrence of ileus,
instances of acute renal failure, the need for temporary he-
modialysis, and the presence of postoperative fever also
predicted LOS > 4 days ( p £ 0.001).
Discussion
As the surgical approach to PN has evolved over the last
decade, with expanding utilization of minimally invasive
surgery and robotics, so have the postoperative expectations.
The experience of RPN continues to mature, conferring
Table 1. Comparison of Patient and Tumor Characteristics, Surgical Technique,
and Perioperative Parameters in Patients Who had Hospital Admission of Less Than (Group 1),
Equal to (Group 2), and Greater Than 4 Days (Group 3)
Group 1 Group 2 Group 3
Variables n = 1298 n = 133 n = 110 p-Value
Patient characteristics
Age, mean (SD), years 58.8 (12) 59.7 (13) 63.5 (11) 0.001
Gender, No. (%)
Male 782 (60.7) 92 (67.1) 71 (66.3) 0.358
Female 506 (39.3) 45 (32.9) 36 (33.7)
Ethnicity, No. (%) 0.462
Caucasian 1033 106 80
African American 182 21 18
Hispanic/Asian 67 16 10
Body mass index, mean (SD) kg/m2 32.2 (6.8) 30.7 (7.1) 30.8 (7.2) 0.134
Age-adjusted CCI, mean (SD) 2.2 (1.7) 3.1 (1.9) 3.8 (2.3) <0.0001
ASA score, mean (SD) 2.5 (0.6) 2.6 (0.6) 2.8 (0.6) <0.0001
Preop eGFR, mean (SD) 86.1 (27.2) 81.2 (28.5) 74.4 (29.2) <0.0001
Solitary kidney, No. (%) 26 (2.0) 11 (8.0) 5 (4.6) 0.265
Previous abdominal surgery, No. (%) 523 (40.6) 63 (46) 51 (51.4) 0.793
Tumor characteristics
Radiographic tumor size, mean (SD) cm 2.9 (1.5) 3.6 (1.7) 3.7 (1.8) <0.0001
Nephrometry score, mean (SD) 7.1 (1.2) 7.6 (1.8) 7.8 (2.0) 0.0002
Tumor laterality, No. (%)
Left 381 (29.6) 73 (53.3) 52 (48.6) 0.730
Right 907 (70.4) 64 (46.7) 55 (51.4)
Tumor location hilar, No. (%) 115 (8.9) 12 (8.7) 4 (3.7) 0.262
Perioperative outcomes
Hilar clamping, No. (%)
Unclamped 61 (4.7) 9 (6.5) 7 (6.5) 0.411
Clamped 1227 (95.3) 128 (93.5) 100 (93.5)
WIT, mean (SD) min 18.7 (8.7) 20.8 (9.6) 23.1 (11.2) <0.0001
Operative time, mean (SD), minutes 175 (55) 197 (58) 200 (63) <0.0001
Blood loss, mean (SD), mL 164 (150) 286 (265) 312 (388) <0.0001
Primary pathology (%)
Benign 286 (22) 22 (16.5) 17 (15.4) 0.0365
Malignant 1012 (78) 111 (83.4) 93 (84.5)
Intraoperative complications, No. (%) 14 (1) 6 (4.3) 5 (4.6)
Postoperative complications, No. (%)
Clavien grade £ 2 94 (7.3) 33 (24) 44 (41.1) <0.0001
Clavien grade ‡ 3 22 (1.7) 7 (5.1) 15 (14.0) <0.0001
Boldface p-values indicate statistical significance.
ASA=American Society of Anesthesiologists; CCI =Charlson comorbidity index; eGFR= estimated glomerular filtration rate;
SD = standard deviation; WIT =warm ischemia time.
FIG. 1. Hospital length of stay stratified by day.
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similar or improved perioperative outcomes with excellent
oncologic control compared with open surgery, and now the
emphasis has begun to shift to secondary outcomes impacting
patient quality of life, procedure cost, and healthcare resource
utilization. Despite the advantages of minimally invasive
surgery, pressures to reduce costs have led many healthcare
organizations to evaluate procedure costs.
It has been suggested that robotic-assisted procedures
currently cost our healthcare system more than the traditional
open approach. Robotic PN has been reported to cost at least
$535 to $1651 more in direct costs than the open surgical
alternative, despite the shorter LOS.15 This estimate, similar
to much of the published literature about robotic RPN, is from
a high-volume center and likely an underestimate of the cost
differential for many lower-volume centers, which often have
longer operative times. Any increased hospital LOS, and
therefore additional indirect costs after RPN, are being clo-
sely monitored and scrutinized as a potential area for cost
savings. There is an emphasis on discharging patients sooner,
a goal that minimally invasive surgery has largely been able
to accomplish. The average LOS after RPN is 1–3 days
compared with 4–8 days after an open PN.16–18 Clinical care
pathways have been designed while emphasizing early dis-
charge after minimally invasive PN, which have achieved
discharge on POD 1 for many patients without a demon-
strated increase in complications.19 However, even with
these strategies performed in centers of excellence by high-
volume surgeons, the early discharge goal is met in only
60%–75% of patients.16,20 In the present series, 84% of pa-
tients were discharged in 1 to 3 days, and 243 patients (16%)
did not meet discharge criteria and required 4 or more days in
the hospital. This demonstrates that not only will 25%–40%
of patients not be able to be discharged in 1 day, but also 15%
of patients will need at least 4 days to meet discharge criteria.
It is, therefore, imperative that we set realistic hospital LOS
expectations for our patients, other surgeons, and those in-
volved in healthcare policy lest we establish an unrealistic
standard that cannot be met in many cases.
This study has several important findings about the oc-
currence of prolonged hospital LOS after RPN. First are the
association with LOS and the nonmodifiable risk factors
of a higher CCI and more complex tumors with higher ne-
phrometry scores. Preoperative comorbidities are a predictor
of longer LOS in univariate and an independent risk factor in
multivariate analysis. Comorbidities are associated with in-
creased postoperative complications after RN,21 and were
found to be the only predictor of an increased 30-day read-
mission rate after robotic PN.22 Patients with a higher CCI are
more likely overall to have postoperative complications23
and as demonstrated in our analyses have a longer LOS. The
R.E.N.A.L. nephrometry score is generally considered to be
predictive of tumor complexity and has been significantly
associated with higher incidence of postoperative complica-
tions.24,25 We found a significant association between ne-
phrometry score and LOS, indicating that for larger, more
complex tumors there is an increased risk of a prolonged
LOS. Neither the patient’s preoperative comorbidities nor
tumor nephrometry score is necessarily modifiable and
may indicate the need for more ‘‘work’’ before, during, and
after surgery, despite an equivalent relative value unit re-
imbursement. Conceptually, this means that in an era of
oversight by governmental and health insurance agencies,
surgeons and healthcare systems should consider these risk
factors and take a proactive approach to preventing any
modifiable complications.
Second is the association with LOS and perioperative
complications, a modifiable risk factor. In this series, we had
an overall complication rate of 14%, which is comparable to
other published reports of complication rates ranging from
0% to 20%.26 In our series, complications occurred in 9% of
patients leaving the hospital in 1 to 3 days, whereas patients
with an LOS of 4 days and 5 or more days experienced
complications in 29.2% and 55.1% respectively. The severity
of complication as graded by the Clavien classification was a
factor in increasing LOS in both univariate and multivariate
analysis. While our study illustrates that any complication
regardless of severity can have a significant impact on LOS,
logically the worse the complication the longer the predicted
hospital LOS.
The most common complication in our series was hem-
orrhagic, which occurred in a total of 85 patients (5.5%), but
occurred in 12.8% of patients with an LOS of 4 days and
25.5% in an LOS of 5 or more days. Of the 55 patients re-
quiring postoperative transfusion, 45.5% stayed in the hos-
pital longer than 4 days and were a significant contributor to
LOS. In the literature, reported rates of bleeding are highly
variable, ranging from 0% to 12%.26,27 Beyond their direct
impact on patient recovery, hemorrhagic complications have
Table 2. Multiple Logistic Regression Analysis
Evaluating the Impact of Baseline Patient
and Tumor Characteristics and Variations
in Surgical Technique on Hospital Length of Stay
Variables OR (95% CI) p-Value
Patient characteristics
Age, years 0.988 (0.97–1.06) 0.201
Gender
Male (referent) 1.34 (0.91–1.98) 0.144
Female
Body mass index, kg/m2 0.72 (0.29–1.78) 0.479
Age-adjusted CCI 2.23 (1.52–3.29) <0.0001
ASA score 1.35 (0.956–1.91) 0.088
Tumor characteristics
Pathologic size, cm 1.27 (0.81–1.99) 0.294
Nephrometry score 1.13 (1.01–1.26) 0.041
Tumor laterality
Left (referent) 0.94 (0.65–1.36) 0.731
Right
Tumor location hilar 0.94 (0.49–1.12) 0.112
Surgical technique and outcomes
Hilar clamping
Unclamped (referent) 1.06 (0.95–1.67) 0.427
Clamped
WIT, minutes 1.01 (0.98–1.04) 0.327
Operative time, mean (SD),
minutes
1.34 (0.69–2.82) 0.355
Blood loss, mean (SD), mL 1.54 (1.19–2.0) 0.001
Primary pathology
Benign 0.79 (0.48–1.31) 0.367
Malignant
Complication Clavien grade 2.27 (1.91–2.7) <0.0001
Boldface p-values indicate statistical significance.
CI = confidence interval; OR= odds ratio.
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Table 4. Postoperative Complications Stratified by Hospital Length of Stay and Organ System
Variable LOS < 4 days LOS= 4 days LOS > 4 p
Number of patients 1298 133 110
Type of complication, n (%)
Hemorrhage 26 (1.6) 17 (12.8) 28 (25.5) <0.001
DVT/PE 1 (0.1) 0 7 (6.4) <0.001
Cardiac 20 (1.7) 9 (7.5) 10 (9.1) <0.001
Pulmonary 20 (1.6) 5 (3) 9 (8.2) <0.001
GI 11 (0.9) 6 (3.8) 9 (8.2) <0.001
Genitourinary 28 (2.2) 9 (9.8) 9 (8.2) <0.001
Infection 7 (0.5) 0 6 (3.6) 0.015
Wound 10 (0.8) 0 0 (0.0) 0.577
Other 11 (0.9) 1 (0.8) 2 (2.7) 0.174
Boldface p-values indicate statistical significance.
LOS= length of stay.
Table 3. Postoperative Complications Classified by Clavien Grade and Organ System
Grade Organ system Complications No. (%)
1 Genitourinary Acute renal failure/insufficiency (4); lymphatic leak (1); perinephric
fluid (1); urinary retention (8); hematuria (5); urine leak (6)
83 (32.5)
Cardiovascular Atrial Fibrillation (4); tachyarrhythmia (3)
Pulmonary Dyspnea (5); atelectasis (5); effusion (1)
Gastrointestinal Ileus (16); diarrhea (2)
Dermatologic Rash (2); ecchymosis (2); wound infection (2)
Psychiatric Psychosis (2)
Other Pain (3); fever (4); port site hernia (1); neuropathy (1); vertigo (1); drop
in blood count not requiring intervention (8); DVT (1)
2 Genitourinary Bleeding requiring transfusion (47); urine leak (4); acute renal failure (3);
urinary tract infection (2)
125 (49)
Cardiovascular Deep vein thrombosis (4); hypertensive crisis (5); tachyarrhythmia (6);
atria fibrillation (10); bradycardia (1); hypotension (3)
Pulmonary Pulmonary embolism (2); pneumonia (4); dyspnea (4); atelectasis (6);
pulmonary edema (4); respiratory insufficiency (2)
Gastrointestinal Clostridium Difficile infection (1); prolonged ileus (6)
Dermatologic Wound infection (3)
Psychiatric Suicidal ideation (1)
Other Pain (3); incisional hernia (1); neuropathy (2); abdominal wall hematoma
requiring transfusion (2)
3a Genitourinary Bleeding requiring angioembolization/pseudoaneurysm (16); urine leak
requiring percutaneous drainage (2)
23 (9.1)
Cardiovascular DVT requiring IVC filter (1)
Pulmonary Pneumothorax requiring chest tube placement (2); pulmonary embolism
requiring IVC filter (2)
3b Genitourinary Urine leak requiring stent (7); obstructing nephrolithiasis requiring
stent (1); postoperative hemorrhage requiring clot evacuation and
nephrectomy (2)
10 (3.9)
4a Genitourinary Acute renal failure requiring hemodialysis (2); renal hemorrhage with
hemodynamic instability requiring transfusion (2); Retroperitoneal
hematoma requiring exploratory evacuation, transfusion (1)
13 (5.1)
Cardiovascular Myocardial infarction (1); delayed splenic rupture resulting in hemodynamic
instability requiring operative exploration and splenectomy (1);
hypertensive crisis (2); symptomatic atrial fibrillation (3); subcapsular
hematoma of liver causing hemodynamic instability (1)
Pulmonary Respiratory compromise secondary to subcutaneous emphysema
requiring intubation (1); pulmonary embolism requiring intubation (1);
4b Cardiovascular Atrial flutter associated with acute renal failure (1) 1 (0.4)
DVT = deep vein thrombosis.
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a measurable secondary effect on the cost of healthcare. A
previous study calculated the increased cost of having a
hemorrhagic complication after LPN to be $5268.28 While
the risk of complication is inherent to any surgical procedure,
when performing an RPN, meticulous surgical technique is
needed not only to avoid acute intraoperative hemorrhage but
also to reduce the incidence of postoperative hemorrhagic
complications that cause morbidity, prolonged LOS, and a
significant increase in the cost to the healthcare system.
Our study found that development of a DVT, pulmonary
embolism, and atrial fibrillation were each significant pre-
dictors of a prolonged LOS. The reported incidence of venous
thromboembolism (VTE) after PN is rare, found in only 1.5%
of patients undergoing radial and PN in a large retrospective
analysis of 2208 patients.29 This study also found that a VTE
event contributed significantly to a longer LOS, although it
was unclear whether perioperative heparin conferred an ad-
ditional benefit over pneumatic compression devices. While
the incidence of VTE in our study is low, found in only 0.05%
of patients, it is clear that development of a VTE has a direct
impact on hospitalization. Consequently, prophylaxis should
be considered in every patient.
Our findings suggest that atrial fibrillation is strongly as-
sociated with greater LOS after PN. Polanczyk et al. found
that 6.1% of patients undergoing noncardiac surgery expe-
rienced an episode of atrial fibrillation, which was associated
with a 33% increase in LOS.30 Several other studies have
suggested that male gender, age > 70, asthma, cardiovascular
disease, ASA class 3 or greater, and intraoperative transfu-
sion may predict postoperative arrhythmia.31,32 While there
is no clear consensus on pharmacologic prophylaxis, identi-
fication preoperatively of high-risk patients may improve
postoperative management and treatment.
This study has certain limitations. This analysis combines
operative data from five large tertiary centers. While this
database incorporates the early learning curves of all
Table 5. Postoperative Complications Classified by Type and Incidence in Length
of Stay Greater Than 4 Days
Organ system Complications Total No. LOS > 4 day (%) p
Hemorrhage Bleeding requiring transfusion 50 20 (40) <0.001
Bleeding requiring angioembolization/pseudoaneurysm 16 2 (12.5) 0.134
Postoperative hematoma/transfusion 5 5 (100) <0.001
DVT/PE DVT 4 4 (100) <0.001
DVT/Pulmonary embolism 4 3 (75) <0.001
Cardiovascular Atrial Fibrillation/flutter 18 5 (27.7) <0.001
Tachyarrhythmia 9 2 (22.2) 0.437
Bradycardia 1 0
Hypertension/hypotension 10 3 (30) 0.014
Myocardial infarction 1 0
Pulmonary Dyspnea/atelectasis 20 6 (30) <0.001
Pulmonary edema/effusion 5 1 (20) 0.267
Pneumonia 4 0
Respiratory insufficiency 2 0
Pneumothorax requiring chest tube placement 2 1 (50) <0.001
Subcutaneous emphysema requiring intubation 1 1 (100) <0.001
Gastrointestinal Ileus 22 9 (41) <0.001
Clostridium Difficile infection/diarrhea 3 0
delayed splenic rupture 1 0
Genitourinary Acute renal failure/insufficiency 7 4 (57) <0.001
Acute renal failure requiring hemodialysis 2 2 (100) <0.001
Lymphatic leak 1 1 (100)
Urine leak 19 2 (10.5) 0.623
urinary retention 8 0
Perinephric fluid 1 0
Hematuria 5 0
Urinary tract infection 2 0
obstructing nephrolithiasis requiring stent 1 0
Dermatologic Rash 2 0
Ecchymosis 2 0
Wound infection 5 0
Psychiatric Psychosis/suicidal ideation 3 0
Other Fever 6 6 (100) <0.001




Drop in blood count not requiring intervention 8 0
Boldface p-values indicate statistical significance.
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individual participating surgeons, the data as a whole reflect
the outcomes from high-volume centers that might not be
reproducible by the general urologic community. Further-
more, the referral of patients with more comorbidities and
tumors with increased complexity to the tertiary care centers
participating in this study introduces selection and referral
bias, which may affect reported outcomes.
This study is also based on a retrospective review of a
prospectively maintained database. Given the prospective
data collection, the quality of the data is higher than what
would be expected from a retrospective study but still lacks
the integrity and accuracy of a randomized trial. There are
also other variables that affect the postoperative course and
LOS that were not captured in our database, such as the need
for anti-coagulation, placement in extended care, social
factors, weather, and travel to a distant location for recov-
ery. Several patients at all centers traveled from outside the
local community for surgery, and all surgeons were biased
toward retaining some of these cases for a longer stay.
Nevertheless, this large, multicenter study demonstrates
appropriate perioperative outcomes for RPN; further studies
evaluating how to prevent complications and a prolonged
LOS are warranted.
Conclusions
There is a significantly longer LOS in patients with the
nonmodifiable risk factor of medical comorbidities, and
complex tumors as well as the modifiable perioperative or
postoperative complications. In an era of rising annual
healthcare expenditure, where in-hospital complications
and prolonged LOS are responsible for significant cost,
urologists will face greater scrutiny with emphasis placed on
reducing these adverse events to improve patient safety and
lower costs. Despite comparable outcomes to other modali-
ties, RPN remains a technically challenging surgery that re-
quires significant experience in minimally invasive
techniques. Long-term reduction of costs through consis-
tently shorter, post-RPN LOS will, thus, require investment
in continued training and evaluation of surgeons in this
technique.
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